Skip to main content
PMC home page
Public Health Reports logoLink to Public Health Reports
. 1990 Mar-Apr;105(2):119–124.

HIV seroprevalence surveys in sexually transmitted disease clinics.

I M Onorato 1, E McCray 1, M Pappaioanou 1, R Johnson 1, S Aral 1, A M Hardy 1, T J Dondero Jr 1
PMCID: PMC1580052  PMID: 2108455

Abstract

The Centers for Disease Control, in cooperation with State and local health departments, is conducting human immunodeficiency virus, type 1 (HIV), seroprevalence surveys, using standard protocols, in sexually transmitted disease (STD) clinics in selected metropolitan areas throughout the United States. The surveys are blinded (serologic test results not identified with a person) as well as nonblinded (clients voluntarily agreeing to participate). STD clinics are important sentinel sites for the surveillance of HIV infection because they serve persons who are at increased risk as a result of certain behaviors, such as unprotected sex, homosexual exposure, or intravenous drug use. HIV seroprevalence rates will be obtained in the sentinel clinics each year so that trends in infection can be assessed over an extended period of time. Behaviors that place clients at risk for infection, or protect against infection, are being evaluated in voluntary, nonblinded surveys to define groups for appropriate interventions and to detect changes in response to education and prevention programs. Although inferences drawn from the surveys are limited by the scope of the clinics and clients surveyed, HIV trends in STD clinic client populations should provide a sensitive monitor of the course of the acquired immunodeficiency syndrome (AIDS) epidemic among persons engaging in high-risk sexual behaviors.

Full text

PDF
119

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dondero T. J., Jr, Pappaioanou M., Curran J. W. Monitoring the levels and trends of HIV infection: the Public Health Service's HIV surveillance program. Public Health Rep. 1988 May-Jun;103(3):213–220. [PMC free article] [PubMed] [Google Scholar]
  2. Holmberg S. D., Stewart J. A., Gerber A. R., Byers R. H., Lee F. K., O'Malley P. M., Nahmias A. J. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA. 1988 Feb 19;259(7):1048–1050. [PubMed] [Google Scholar]
  3. Hull H. F., Bettinger C. J., Gallaher M. M., Keller N. M., Wilson J., Mertz G. J. Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic. JAMA. 1988 Aug 19;260(7):935–938. [PubMed] [Google Scholar]
  4. Schalla W. O., Hearn T. L., Taylor R. N., Eavenson E., Valdiserri R. O., Essien J. D. CDC's Model Performance Evaluation Program: assessment of the quality of laboratory performance for HIV-1 antibody testing. Public Health Rep. 1990 Mar-Apr;105(2):167–171. [PMC free article] [PubMed] [Google Scholar]
  5. Schmid G. P., Sanders L. L., Jr, Blount J. H., Alexander E. R. Chancroid in the United States. Reestablishment of an old disease. JAMA. 1987 Dec 11;258(22):3265–3268. [PubMed] [Google Scholar]
  6. Simonsen J. N., Cameron D. W., Gakinya M. N., Ndinya-Achola J. O., D'Costa L. J., Karasira P., Cheang M., Ronald A. R., Piot P., Plummer F. A. Human immunodeficiency virus infection among men with sexually transmitted diseases. Experience from a center in Africa. N Engl J Med. 1988 Aug 4;319(5):274–278. doi: 10.1056/NEJM198808043190504. [DOI] [PubMed] [Google Scholar]
  7. Stamm W. E., Handsfield H. H., Rompalo A. M., Ashley R. L., Roberts P. L., Corey L. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA. 1988 Sep 9;260(10):1429–1433. [PubMed] [Google Scholar]

Articles from Public Health Reports are provided here courtesy of SAGE Publications

RESOURCES